A histamine H3 and H4 receptor agonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Imetit (hydrobromide)

Item No. 29517

Technical Information
Formal Name
carbamimidothioic acid, 2-(1H-imidazol-5-yl)ethyl ester, dihydrobromide
CAS Number
32385-58-3
Synonyms
  • VUF 8325
Molecular Formula
C6H10N4S • 2HBr
Formula Weight
Purity
≥95%
Formulation
A solid
SMILES
NC(SCCC1=CN=CN1)=N.Br.Br
InChi Code
InChI=1S/C6H10N4S.2BrH/c7-6(8)11-2-1-5-3-9-4-10-5;;/h3-4H,1-2H2,(H3,7,8)(H,9,10);2*1H
InChi Key
DOBOYMKCRRLTRF-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Imetit is a histamine H3 and H4 receptor agonist (Kis = 0.3 and 2.7 nM, respectively, in radioligand binding assays).1 It is selective for histamine H3 and H4 receptors over H1 and H2 receptors at concentrations up to 100 µM, as well as the serotonin (5-HT) receptor subtype 5-HT3 (Ki = 240 nM).2,3 Imetit reduces potassium-induced increases in histamine levels in isolated rat cerebral cortex slices (EC50 = 2.8 nM).4 It increases scratching in mice (ED50 = 0.9 µmol), an effect that is reduced by the H3 receptor antagonist thioperamide (Item No. 10011127).5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Liu, C., Ma, X., Jiang, X., et alCloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol. Pharmacol. 59(3), 420-426 (2001).

    2. Howson, W., Michael, E., Parsons, P.R., et alTwo novel, potent and selective histamine H3 receptor agonists. Bioorg. Med. Chem. Lett. 2(1), 77-78 (1992).

    3. Leurs, R., Tulo, M.T., Menge, W.M., et alEvaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. Br. J. Pharmacol. 116(4), 2315-2321 (1995).

    4. Garbarg, M., Arrang, J.M., Rouleau, A., et alS-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. J. Pharmacol. Exp. Ther. 263(1), 304-310 (1992).

    5. Bell, J.K., McQueen, D.S., and Rees, J.L. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in BalbC mice. Br. J. Pharmacol. 142(2), 374-380 (2004).